What is HC Wainwright's Forecast for Balchem Q4 Earnings?

Balchem Co. (NASDAQ:BCPC - Free Report) - Stock analysts at HC Wainwright issued their Q4 2026 EPS estimates for Balchem in a research report issued on Monday, February 24th. HC Wainwright analyst R. Selvaraju anticipates that the basic materials company will post earnings of $1.22 per share for the quarter. HC Wainwright currently has a "Buy" rating and a $190.00 price target on the stock. The consensus estimate for Balchem's current full-year earnings is $4.64 per share.

Several other brokerages have also commented on BCPC. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday. Sidoti upgraded Balchem to a "hold" rating in a research report on Tuesday.

Balchem Stock Up 1.2 %

Balchem stock traded up $2.03 during mid-day trading on Tuesday, hitting $174.03. The company had a trading volume of 134,481 shares, compared to its average volume of 131,741. The stock has a market cap of $5.66 billion, a price-to-earnings ratio of 44.28, a PEG ratio of 4.41 and a beta of 0.69. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. Balchem has a 1 year low of $137.69 and a 1 year high of $186.03. The business has a fifty day moving average of $162.24 and a 200 day moving average of $169.48.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million during the quarter, compared to analysts' expectations of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%.

Balchem Increases Dividend

The firm also recently declared an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were given a $0.87 dividend. This is an increase from Balchem's previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. This represents a yield of 0.4%. Balchem's dividend payout ratio is 22.14%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Creative Planning grew its holdings in shares of Balchem by 33.4% during the third quarter. Creative Planning now owns 9,777 shares of the basic materials company's stock worth $1,721,000 after buying an additional 2,449 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Balchem by 642.5% in the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company's stock valued at $148,000 after purchasing an additional 726 shares during the period. Raymond James & Associates raised its stake in shares of Balchem by 7.4% during the third quarter. Raymond James & Associates now owns 54,089 shares of the basic materials company's stock worth $9,520,000 after purchasing an additional 3,741 shares during the last quarter. Private Advisor Group LLC acquired a new stake in shares of Balchem during the third quarter worth $220,000. Finally, First Trust Direct Indexing L.P. grew its position in Balchem by 12.5% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 1,589 shares of the basic materials company's stock valued at $280,000 after buying an additional 177 shares during the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.